After the government allowed 100% foreign direct investment (FDI) in single brand retail, civil aviation, defence, airports, pharmaceuticals, food products and animal husbandry, the US India Business Council (USIBC), has said that the widened scope of FDI norms in this sector will provide a fillip to the potential of the US-India bilateral trade.
USIBC President Mukesh Aghi stated that, 'We applaud the liberalisation of FDI to 74 per cent in brownfield investments under the automatic route in the pharmaceutical sector, while also allowing investments beyond 74 per cent and up to 100 per cent through government approval.' He added that, allowing up to 74% FDI in pharmaceutical sector through the automatic rout will encourage investment to move swiftly into India and will further promote and expand healthcare access in India.
These reforms include accelerated infrastructure investment, greater openness to FDI, less red tape, and a revised bankruptcy code. USIBC President said, 'We had stated earlier that $45 billion is only a starting point for American companies to invest in India. With these newly announced reforms, FDIs, technology transfers, and jobs are likely to increase substantially.”
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: